<qa>  What is the response rate in patients with relapsed or refractory aggressive B- Determine the response rate complete and partial remission in patients with relapsed or refractory aggressive B- or T-cell non-Hodgkins lymphoma treated with gemcitabine hydrochloride and bortezomib. 